AARDVARK THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL OCTOBER 13, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

Bernstein Liebhard LLP issued a shareholder-solicitation notice reminding Aardvark Therapeutics investors of the October 13, 2026 lead plaintiff deadline in a pending securities fraud class action against the company. The suit covers purchasers of Aardvark common stock in or traceable to the February 13, 2025 IPO, or between February 13, 2025 and May 14, 2026, alleging materially false and misleading statements about business operations, growth prospects, and financial stability under the Securities Act of 1933 and the Securities Exchange Act of 1934.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.